1. Josep Carreras Leukemia Research Institute, Barcelona, Spain;
2. Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain;
3. Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Barcelona, Spain;
4. Institute of Oncology of Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, Hospital Universitario Central de Asturias, Oviedo, Spain;
5. Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom;
6. Instituto de Biomedicina y Biotecnología de Cantabria, Universidad de Cantabria–CSIC, Santander, Spain;
7. Dreamgenics S.L., Oviedo, Spain;
8. Service d’Hématologie Biologique, Hospital Armand Trousseau, Paris, France;
9. Hématologie Biologique, Centre de Recherche Saint-Antoine, Hospital Saint-Antoine, Inserm, Sorbonne Université, Paris, France;
10. Department of Pediatric Hemato-oncology, Hospital Armand Trousseau, Paris, France;
11. Nanomaterials and Nanotechnology Research Center, Universidad de Oviedo, Oviedo, Spain; and
12. Instituciò Catalana de Recerca i Estudis Avançats, Barcelona, Spain